Arcoxia
Indicated to address chronic pain, developed to relieve inflammation and to support mobility in joints affected by arthritis.
Strengths: 60 · 90 · 120mg
Where to Check Availability
Medicine details
- Therapeutic class
COX-2 Inhibitor
- Pharmacological class
NSAID
- Minor side effects
dizziness; fatigue; nausea
- Moderate side effects
hypertension; peripheral oedema; dyspepsia
- Dosage forms
Film-coated tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Merck Sharp & Dohme
- Onset Time
24–48 hours
- Duration
24 hours
- Storage instructions
Store in a cool, dry place.
- Drug interactions
warfarin; lithium; methotrexate
- Age restrictions
Not recommended for patients under 16 years.
- Pregnancy and breastfeeding
Pregnancy: Do not use. Breastfeeding: Not recommended.
Contraindications
history of cardiovascular disease; uncontrolled hypertension; active gastric ulcer; severe hepatic impairment
Precautions and warnings
monitor blood pressure regularly; caution in elderly patients; avoid if history of inflammatory bowel disease
Serious side effects
myocardial infarction — requires immediate medical attention; stroke — requires immediate medical attention; gastrointestinal perforation — requires immediate medical attention
Patient summary
Indicated to address chronic pain, developed to relieve inflammation and to support mobility in joints affected by arthritis.
Mechanism of action
Etoricoxib is a selective cyclooxygenase-2 (COX-2) inhibitor that reduces the formation of inflammatory prostaglandins while sparing COX-1, potentially causing fewer gastric side effects compared to non-selective NSAIDs.
Arcoxia
Indicated to address chronic pain, developed to relieve inflammation and to support mobility in joints affected by arthritis.
Editorial Notes
- Active ingredient(s): Etoricoxib
- Listed indication(s): Osteoarthritis, Rheumatoid Arthritis, Gouty Arthritis
Usually available as
- 180 tablets - 60 mg567-60-mg-2062
- 90 tablets - 90 mg567-90-mg-2072
- 60 tablets - 120 mg567-120-mg-2065